ANTICONVULSANT DRUGS MARKET ANALYSIS
Global Anticonvulsant Drugs Market: Key Developments
In June 2022, the Government of Manitoba, a Canadian province, announced an annual investment of more than US$ 2.5 million in operating funding to support the establishment of the adult epilepsy surgery program, as well as the expansion of the pediatric program, which has completed about 15 surgeries per year since 2017. When the expanded program will be fully operational, around 50 epilepsy surgeries will be completed per year in Manitoba including 20 adult and 30 pediatric cases. The program, including surgeries, will be run at Health Sciences Centre (HSC) Winnipeg, a hospital in Manitoba.
Global Anticonvulsant Drugs Market: Restraint
Increasing number of product recall by regulatory authorities such U.S. Food and Drug Administration is expected to hamper the growth of anticonvulsant drugs market. For instance, in January 2022, U.S. Food and Drug Administration recalled 15,336 bottles of 200-mg carbamazepine tablets, which was manufactured by Torrent Pharmaceuticals Ltd., a pharmaceutical company. The product was recalled because samples failed to meet dissolution specifications during testing.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
